Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Progenics Pharmaceuticals buy Quitte

Start price
€3.85
30.01.14 / 50%
Target price
€4.30
25.03.14
Performance (%)
-20.86%
End price
€3.05
25.03.14
Summary
This prediction ended on 25.03.14 with a price of €3.05. The prediction for Progenics Pharmaceuticals disappointed with a performance of -20.86%. Quitte has 50% into this prediction
Performance without dividends (%)
Name 1w 1m 1y 3y
Progenics Pharmaceuticals - - - -
iShares Core DAX® -0.612% 0.567% 12.585% 14.838%
iShares Nasdaq 100 -3.018% -3.205% 26.208% 38.328%
iShares Nikkei 225® -2.647% 0.330% 9.482% 5.652%
iShares S&P 500 -1.932% -1.126% 23.191% 38.791%

Comments by Quitte for this prediction

In the thread Progenics Pharmaceuticals diskutieren
Prediction Buy
Perf. (%) -20.86%
Target price 4.300
Change
Ends at 25.03.14

die machen weiter und werden im 2. Anlauf wahrscheinlich erfolgreicher sein

nach dem Rückschlag mit einem Medikament in der Versuchsphase (zwei Tote) stürzte  die Aktie ab. Ich halte das für einen guten Einstieg, weil  die Firma weiter machen wird.

Spekulation!

Prediction Buy
Perf. (%) -20.86%
Target price 4.300
Change
Ends at 25.03.14

(Vom Mitglied beendet)

Stopped prediction by Quitte for Progenics Pharmaceuticals

buy
Progenics Pharmaceuticals

Start price
Target price
Perf. (%)
€4.05
22.08.19
€5.00
29.06.20
-8.07%
29.06.20

buy
Progenics Pharmaceuticals

Start price
Target price
Perf. (%)
€5.40
18.09.18
€7.22
18.03.19
-24.21%
18.03.19

buy
Progenics Pharmaceuticals

Start price
Target price
Perf. (%)
€7.50
16.03.18
€9.47
17.09.18
-32.51%
17.09.18